drugset / Trial / NCT03631121

Effects of Replacing Lantus With Basalin on the Glycemic Variation in Patients With Type 2 Diabetes Mellitus

NCT03631121 ↗

NaSingle-groupOpen-labelTreatment

Summary

The study will assess the glycemic variationusing continuous glucose monitoring system in type 2 diabetic patients with euglycemia control respectively when patients was treated with Basalin and one week after changing the insulin into Lantus.

Timeline

Start
2018-08-15
Primary completion
2018-12-31
Completion
2019-07-30

Drugs

EvaluationDrugModalityDoseRoute
Subject insulin glargine Protein / enzyme biologic — —